|
|
|||
Volcano
and Cordis Endovascular Japan Announce Distribution Agreement
for IVUS Indications
Agreement Expected to Continue Volcano's Leadership Position in Peripheral IVUS in Japan |
|||
Volcano Corporation, which completed its IPO in June 2006, offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart diseases and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab and single-use phased array and rotational IVUS imaging catheters. Volcano also has unique advanced functionality options like VH tissue characterization and IVUS and angiography co-registration. Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires. Currently, more than 2,500 Volcano IVUS and FM systems are installed worldwide, with approximately half of its revenues coming from outside the United States. For more information, visit the company's website at www.volcanocorp.com. Forward-Looking Statements This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Statements in this press release regarding Volcano's business that are not historical facts may be "forward-looking statements" that involve risks and uncertainties. Specifically statements regarding the successful execution of collaboration agreements and relationships, ease of product use, the performance of the company's IVUS systems, customer acceptance and use of the company's products and technologies, the role of IVUS technology in optimizing stent placement, the role of IVUS in clarifying atherosclerotic disease process and guiding interventional and system therapies and the availability or results of clinical trial and collaboration activities are forward-looking statements that involve risks and uncertainties. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Volcano's results to differ materially from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from the results presented are detailed in the company's 10-Q, most recent Registration Statement on Form S-1 and other filings made with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Volcano undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events. Source: Volcano Corporation |
|||
Angioplasty.Org Home • PatientCenter send comments & suggestions to "info at angioplasty
dot org" |